Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: swimming pool water
DNA G+C(%): 64-68
|
High T(℃): 41(+)
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
Augmentin: S(MIC50): 0.5, MIC90: 1, RNG: (0.5–1)
piper-taz: S(MIC50): 0.5, MIC90: 0.5, RNG: (0.5–4)
imipenem: S(MIC50): 0.125, MIC90: 0.125, RNG: (0.125)
|
cefotetan: S(MIC50): 0.5, MIC90: 0.5, RNG: (0.5–2)
cefoxitin: S(MIC50): 1, MIC90: 2, RNG: (0.5–16)
|
gentamicin: S(MIC50): 1, MIC90: 2, RNG: (1–2)
|
|
ciprofloxacin: S(MIC50): 0.03, MIC90: 0.25, RNG: (0.03–0.5)
levofloxacin: S(MIC50): 0.015, MIC90: 0.03, RNG: (0.015–0.03)
ofloxacin: S(MIC50): 0.015, MIC90: 0.015, RNG: (0.015–0.125)
trovafloxacin: S(MIC50): 0.015, MIC90: 0.06, RNG: (0.015–0.125)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
|
|
|
|